ScoreWhy is COSMOS Pharmaceutical Corp. ?
1
Weak Long Term Fundamental Strength with a 2.72% CAGR growth in Operating Profits over the last 5 years
2
Poor long term growth as Operating profit has grown by an annual rate 2.72% of over the last 5 years
3
The company has declared Negative results for the last 11 consecutive quarters
- INTEREST(HY) At JPY 214 MM has Grown at 122.92%
- INVENTORY TURNOVER RATIO(HY) Lowest at 9.02 times
- DEBT-EQUITY RATIO (HY) Highest at 7.25 %
4
Consistent Underperformance against the benchmark over the last 3 years
- Along with generating -35.01% returns in the last 1 year, the stock has also underperformed Japan Nikkei 225 in each of the last 3 annual periods
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Retailing)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is COSMOS Pharmaceutical Corp. for you?
Low Risk, Low Return
Absolute
Risk Adjusted
Volatility
COSMOS Pharmaceutical Corp.
-34.8%
-0.09
32.36%
Japan Nikkei 225
59.79%
2.06
29.57%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
7.84%
EBIT Growth (5y)
2.72%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
Net Debt is too low
Net Debt to Equity (avg)
-0.05
Sales to Capital Employed (avg)
3.60
Tax Ratio
26.68%
Dividend Payout Ratio
17.91%
Pledged Shares
0
Institutional Holding
0.02%
ROCE (avg)
15.74%
ROE (avg)
12.58%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
15
Industry P/E
Price to Book Value
1.75
EV to EBIT
12.25
EV to EBITDA
7.72
EV to Capital Employed
1.70
EV to Sales
0.47
PEG Ratio
3.09
Dividend Yield
NA
ROCE (Latest)
13.87%
ROE (Latest)
11.48%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
No Trend
No Trend
OBV
Mildly Bullish
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend2What is working for the Company
NET SALES(Q)
Highest at JPY 273,205 MM
OPERATING PROFIT(Q)
Highest at JPY 17,587 MM
-11What is not working for the Company
INTEREST(HY)
At JPY 214 MM has Grown at 122.92%
INVENTORY TURNOVER RATIO(HY)
Lowest at 9.02 times
DEBT-EQUITY RATIO
(HY)
Highest at 7.25 %
Here's what is working for COSMOS Pharmaceutical Corp.
Net Sales
Highest at JPY 273,205 MM
in the last five periodsMOJO Watch
Near term sales trend is positive
Net Sales (JPY MM)
Operating Profit
Highest at JPY 17,587 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (JPY MM)
Depreciation
Highest at JPY 6,242 MM
in the last five periodsMOJO Watch
The expenditure on assets done by the company may have gone into operation
Depreciation (JPY MM)
Here's what is not working for COSMOS Pharmaceutical Corp.
Interest
At JPY 214 MM has Grown at 122.92%
over previous Semi-Annual periodMOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (JPY MM)
Inventory Turnover Ratio
Lowest at 9.02 times and Fallen
In each half year in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling inventory has slowed
Inventory Turnover Ratio
Debt-Equity Ratio
Highest at 7.25 %
in the last five Semi-Annual periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
